Transition of recombinant allergens from bench to clinical application.

Transition of recombinant allergens from bench to clinical application.

Item
http://www.wikidata.org/entity/Q35667003
Expression of the major mugwort pollen allergen Art v 1 in tobacco plants and cell cultures: problems and perspectives for allergen production in plants.Cloning, expression, and analysis of a cDNA coding for the Dermatophagoides farinae group 21 (Der f 21) allergen.Peptide-induced immune regulation by a promiscuous and immunodominant CD4T-cell epitope of Timothy grass pollen: a role of Cbl-b and Itch in regulationThe Dermatophagoides farinae group 22 allergen: cloning and expression in Escherichia coli.Latex allergy: a model for therapy.Vaccination with genetically engineered allergens prevents progression of allergic disease.Factors influencing the quality of Myrmecia pilosula (Jack Jumper) ant venom for use in in vitro and in vivo diagnoses of allergen sensitization and in allergen immunotherapy.Nanoparticle-allergen interactions mediate human allergic responses: protein corona characterization and cellular responses.Successive multiple ionic polymer layer coated capillaries in the separation of proteins - recombinant allergen variants as a case study.Generation of a low immunoglobulin E-binding mutant of the timothy grass pollen major allergen Phl p 5a.Production of recombinant allergens in plants.[Specific immunotherapy : clinical experience with recombinant molecular major allergens and hypoallergenic variants].Standardization of allergen products: 2. Detailed characterization of GMP-produced recombinant Phl p 5.0109 as European Pharmacopoeia reference standard.
P2860

Transition of recombinant allergens from bench to clinical application.

Item
http://www.wikidata.org/entity/Q35667003
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Transition of recombinant allergens from bench to clinical application.
@ast
Transition of recombinant allergens from bench to clinical application.
@en
type
label
Transition of recombinant allergens from bench to clinical application.
@ast
Transition of recombinant allergens from bench to clinical application.
@en
prefLabel
Transition of recombinant allergens from bench to clinical application.
@ast
Transition of recombinant allergens from bench to clinical application.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Transition of recombinant allergens from bench to clinical application.
@en
P2093
P304
P31
P356
10.1016/J.YMETH.2003.08.009
P433
P478
P577
P698